CGA CPA - PreveCeutical Medical CFO Controller
PRVCF Stock | USD 0.02 0 9.76% |
Insider
CGA CPA is CFO Controller of PreveCeutical Medical
Age | 67 |
Phone | 604 416 7777 |
Web | https://www.preveceutical.com |
PreveCeutical Medical Management Efficiency
The company has return on total asset (ROA) of (3.3124) % which means that it has lost $3.3124 on every $100 spent on assets. This is way below average. PreveCeutical Medical's management efficiency ratios could be used to measure how well PreveCeutical Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
WenChen MD | Surrozen | 60 | |
Victoria Rac | Bio Path Holdings | N/A | |
MBA MD | Monopar Therapeutics | 38 | |
Charles Williams | Surrozen | 45 | |
Craig Lewis | Benitec Biopharma Ltd | N/A | |
Kristine Rosse | Protara Therapeutics | N/A | |
Jeffery MD | Bio Path Holdings | N/A | |
Elizabeth Nguyen | Surrozen | N/A | |
Calvin MD | Surrozen | N/A | |
Thomas Walker | Bio Path Holdings | N/A | |
MBA MD | Surrozen | 56 | |
Christopher Garcia | Surrozen | N/A | |
MS JD | Surrozen | 62 | |
MBA MPH | Protara Therapeutics | 41 | |
Alan MacKenzie | Bio Path Holdings | N/A | |
David Jin | Fortress Biotech Pref | 33 | |
Peter MBA | Bio Path Holdings | 76 | |
Andrew MBA | Monopar Therapeutics | 53 | |
Samuel Berry | Fortress Biotech Pref | N/A | |
Thomas Schaible | Fortress Biotech Pref | N/A | |
Hannah Fry | Protara Therapeutics | 34 |
Management Performance
Return On Asset | -3.31 |
PreveCeutical Medical Leadership Team
Elected by the shareholders, the PreveCeutical Medical's board of directors comprises two types of representatives: PreveCeutical Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PreveCeutical. The board's role is to monitor PreveCeutical Medical's management team and ensure that shareholders' interests are well served. PreveCeutical Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PreveCeutical Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Makarand Jawadekar, Pres Officer | ||
CGA CPA, CFO Controller | ||
Stephen Deventer, Chairman CEO | ||
Parekh BSc, Chief Officer |
PreveCeutical Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is PreveCeutical Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -3.31 | |||
Current Valuation | 12.06 M | |||
Shares Outstanding | 523.3 M | |||
Shares Owned By Insiders | 24.08 % | |||
Price To Sales | 3,902 X | |||
Gross Profit | 2.25 K | |||
EBITDA | (1.28 M) | |||
Net Income | (1.73 M) | |||
Cash And Equivalents | 2.64 K | |||
Total Debt | 1.68 M |
Currently Active Assets on Macroaxis
Other Information on Investing in PreveCeutical OTC Stock
PreveCeutical Medical financial ratios help investors to determine whether PreveCeutical OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PreveCeutical with respect to the benefits of owning PreveCeutical Medical security.